It is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Under the exemplary leadership and guidance of our expert professionals, we are engaged in offering Capecitabine. It is used in the treatment of esophageal, gastric, hepatobiliary, neuroendocrine, pancreatic, ovarian, fallopian tube, peritoneal and unknown primary cancers. It can be used in combination with docetaxel for the treatment of metastatic breast cancer in patients who have failed to respond to anthracycline-containing chemotherapy. Capecitabine can be taken with or without food by mouth.
Product Name : Capecitabine
Chemical Names : Xeloda; Capiibine; Capecitibine; capecitabinum; capecitabina; Captabin; Capecitabin;
Molecular Formula : C15H22FN3O6
Molecular Weight : 359.354 g/mol
IUPAC Name : pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
CAS Number : 154361-50-9
Physical Description : Solid
Color : White to off-white crystalline powder
Melting Point : 110 - 121 Â°C
Stability : Capecitabine tablets reportedly are stable for at least 9 months when stored in tightly closed containers at room temperature.